Home » Topics » Regulatory

Regulatory
RSS

Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status

Dec. 7, 2015

FDA approves Empliciti for previously treated multiple myeloma

Dec. 1, 2015

FDA approves Portrazza for metastatic squamous NSCLC

Nov. 25, 2015

FDA approves Opdivo for renal cell carcinoma

Nov. 24, 2015

Oxaliplatin and capecitabine regimen approved for gastric cancer adjuvant therapy in Japan

Nov. 23, 2015

FDA approves Ninlaro for multiple myeloma

Nov. 23, 2015

First FDA approval of naloxone nasal spray for opioid overdose

Nov. 19, 2015

FDA first to approve Darzalex for multiple myeloma

Nov. 17, 2015

Two Baxalta hemophilia A products approved in Europe, U.S.

Nov. 16, 2015

FDA approves Tagrisso to treat certain patients with NSCLC

Nov. 16, 2015